UNC-Chapel Hill To Conduct COVID-19 Vaccine Trials
The University of North Carolina is among the new sites for a COVID-19 vaccine trial.
Teams at UNC-Chapel Hill are readying a new recruitment website for volunteers to take part in a Phase 3 clinical trial for a coronavirus vaccine.
The News & Observer reports the test vaccine is being developed by Moderna, a private research company.
In addition to analyzing genetic responses to the virus, scientists want to better understand why people have had so many different reactions to COVID-19.
People who have recovered from the disease can also sign up to donate plasma, which contains antibodies that may help new patients fight off the virus.
Scientists at UNC warn that people need to be patient when it comes to vaccine development.
They say trials take time, and require many participants from across the county to ensure success.
UNC has become a hot spot for COVID-19 research, with a number of clinical trials already underway.